Improving Outcomes in Head and Neck Cancer: The Role of Customized Radiation Carriers

Radiation therapy (RT) is a cornerstone in treating head and neck cancers, but it often comes with a significant cost to the patient’s quality of life. The high-energy beams required to destroy tumors can inadvertently damage healthy surrounding tissues, leading to painful and debilitating oral complications. To combat this, specialists use customized protective and positioning devices, including radiation carriers, to shield healthy areas and ensure the treatment is as precise as possible.

The Challenges of Head and Neck Radiotherapy

Even as radiation is effective at targeting cancer, it frequently causes several oral complications that can hinder a patient’s recovery and daily functioning. These common side effects include:

• Radiomucitis: Inflammation of the oral mucosa.
• Hyposalivation: A significant decrease in saliva production, leading to chronic dry mouth.
• Osteoradionecrosis: Death of bone tissue caused by radiation.
• Physical Limitations: Including oral pain and a restricted ability to open the mouth.

What Are Radiation Carrier and Positioning Devices?

Intraoral devices are designed to work in tandem with conventional radiotherapy to reduce the complications listed above. These tools serve several critical functions: they protect healthy tissues surrounding the target site, carry the radiation source directly to the tumor, and help move the radiation away from sensitive anatomical structures.

Because radiotherapy typically occurs over a treatment period of six to eight weeks, these devices are essential for repetitive repositioning. This ensures that the radiation beam hits the same precise spot every time, limiting damage to the surrounding healthy areas.

Types of Radiation Carrier Devices

Depending on the treatment goals and the location of the cancer, clinicians use different types of carrier devices:

Pre-charged Devices

In these devices, the radioactive sources are placed and sealed within a carrier, such as a polyethylene tube, before being applied to the treatment area.

Afterloading Applicators

These act as guides rather than containers. Plastic probes are inserted interstitially into the tumor area or applied close to the tumor, and the radiation source is “loaded” into these probes after they’re already in position.

Materials and Modern Innovation

The effectiveness of these devices depends heavily on the materials used to build them. Common materials include:

• Thermopolymerizable polymethyl methacrylate resin: Used for its stability and biocompatibility.
• Lead blocks: Used for heavy-duty shielding of healthy tissues.
• Wood’s metal (Cerrobend alloy): A specialized alloy used for precision shielding.

The field is currently shifting toward computer-aided manufacturing design (CAD/CAM). The use of 3D printing for oral radiation devices can significantly improve patient comfort and provide more accurate predictive values for dosimetry, ensuring the patient receives the exact dose of radiation needed without unnecessary exposure to healthy tissue.

The Need for Interdisciplinary Collaboration

Customizing a radiation carrier isn’t a one-person job. Success requires close collaboration between the radiotherapist or oncologist and the maxillofacial prosthodontics (PMF) specialist. This partnership ensures that the device is anatomically accurate, comfortable for the patient, and clinically effective in delivering the radiation dose.

Frequently Asked Questions

How do these devices help with mouth opening?

By protecting the surrounding healthy tissues and reducing inflammation and scarring (like radiomucitis), these devices help mitigate the limitation of mouth opening often associated with radiation therapy.

Why is 3D printing better than traditional methods?

3D printing via CAD/CAM allows for a more precise fit to the patient’s unique anatomy, which increases comfort and improves the accuracy of the radiation dose (dosimetry).

Who decides which device is used?

The choice of device is a collaborative decision made between the oncologist, who manages the cancer treatment, and the maxillofacial prosthodontist, who specializes in the design and fit of the intraoral device.